How Does It Work? The Mechanism of Action

PBM's mechanism occurs in a three-tiered cascade: primary photochemical events at the cellular level, secondary signaling events within the cell, and tertiary systemic effects at the tissue and organ level.[^7]

Primary Target: Cytochrome c Oxidase (CCO)

The primary and best-characterized chromophore in PBM is cytochrome c oxidase (CCO), Complex IV of the mitochondrial electron transport chain (ETC). When photons in the red (600–700 nm) range are absorbed by CCO, they displace inhibitory nitric oxide (NO) that had been blocking the enzyme's active site, thereby reactivating it. This restores normal mitochondrial function, particularly in cells under physiological stress or pathological inhibition.[8][1][7][4]

Near-infrared wavelengths (810–1064 nm) are additionally absorbed by light-sensitive ion channels, including members of the transient receptor potential (TRP) family, increasing intracellular calcium ion (Ca²⁺) flux.[^4]

Secondary Messengers Activated

Following CCO activation, a cascade of secondary messengers is generated:[1][7][^4]

  • ATP (Adenosine Triphosphate): Increased ETC activity drives a rise in mitochondrial membrane potential and ATP synthesis, restoring energy-depleted cells

  • Nitric Oxide (NO): Displaced from CCO, free NO acts as a vasodilator and cellular signaling molecule, improving local microcirculation

  • Reactive Oxygen Species (ROS): Generated in low, signaling-level quantities — at this level, ROS activate pro-survival and anti-inflammatory transcription factors rather than causing oxidative damage

  • Calcium ions (Ca²⁺): Increased intracellular Ca²⁺ interacts with ROS and cyclic AMP (cAMP) to further activate downstream transcription factors

Tertiary Effects: Gene Expression and Tissue Response

These secondary messengers activate key transcription factors — including NF-κB, AP-1, and HIF-1α — which upregulate genes governing:[7][8][^4]

  • Cell proliferation, survival, and migration

  • Collagen synthesis and extracellular matrix remodeling

  • Angiogenesis (via VEGF upregulation)

  • Anti-inflammatory cytokine profiles (increased IL-10, reduced TNF-α, IL-1β, IL-6)

  • Antioxidant enzyme production (superoxide dismutase, catalase)

The Biphasic Dose-Response (Arndt-Schulz Principle)

A critical concept for clinical application is the biphasic dose-response: low-to-moderate doses of light stimulate biological activity, while excessive doses inhibit it. The generally accepted optimal energy density for stimulatory effects is 1–8 J/cm² at the target tissue level, though higher doses (10–30 J/cm²) may be appropriate for analgesic effects involving deeper, subsurface pathologies. This dose-dependence underscores why poorly dosed studies — particularly early ones using insufficient irradiance — have produced null results.[9][3][7][4]

Valerie Krossin

As a nurse and educator with over 16 years of experience in the field of photobiomodulation (PBM), I have witnessed firsthand the transformative impact of this innovative therapy on pain, healing and sports recovery and performance enhancement. As the Educational Director and Senior Account Manager for industry leaders ASPEN Laser and TheraLight, I have been instrumental in forming strategic alliances with health professionals, businesses, individuals and professional and collegiate teams.

PBM harnesses the power of specific wavelengths of light, particularly in the red and near-infrared spectrum, to stimulate cellular processes such as ATP production, enhance mitochondrial function, reduce inflammation, promote tissue repair, and modulate biological responses like gene expression and ion channel activity. These benefits make near-infrared light a versatile tool in PBM, with applications ranging from athlete recovery and performance improvement and pain management to potential treatments for complex neurological conditions.

My unique perspective, combining over two decades of nursing experience with expertise in cutting-edge PBM technology, has allowed me to bridge the gap between clinical practice and sports medicine. This is evident in my recent work, including an abstract accepted by the American Society for Laser Medicine and Surgery (ASLMS) for E-Poster Presentation on Transcranial PBM for treating neurodegenerative diseases.

As the field of PBM continues to evolve, I remain committed to advancing its science and application in sports medicine. We are opening new frontiers in athletic performance and recovery, providing athletes with safe, effective, and non-invasive methods to optimize their potential.

https://www.photobiomodulation.expert
Previous
Previous

What Is LED Photobiomodulation?

Next
Next

Clinical Evidence by Domain